LifeVantage Corp. (LFVN)
10.53
+0.56
(+5.62%)
USD |
NASDAQ |
Jun 08, 15:36
LifeVantage EPS Diluted (Quarterly) : 0.1076 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Niagen Bioscience, Inc. | 0.0747 |
| Mannatech, Inc. | 0.492 |
| Nature's Sunshine Products, Inc. | 0.2855 |
| Cyanotech Corp. | -0.0311 |
| Natural Alternatives International, Inc. | -0.7155 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.362M |
| Revenue (Quarterly) | 43.72M |
| Total Expenses (Quarterly) | 42.35M |
| Enterprise Value | 123.43M |
| Gross Profit Margin (Quarterly) | 79.02% |
| Profit Margin (Quarterly) | 3.12% |
| Earnings Yield | 4.23% |
| Operating Earnings Yield | 4.86% |
| Normalized Earnings Yield | 4.225 |